Lunit Reaches 1 Million Mammograms in U.S. After Volpara Acquisition

Lunit Reaches 1 Million Mammograms in U.S. After Volpara Acquisition

Lunit has achieved a significant milestone by surpassing one million mammograms in the U.S., a year after acquiring Volpara Health, according to a press release.

Lunit has surpassed one million mammograms in the U.S., a year after acquiring Volpara Health, announced in a press release. This milestone marks a significant expansion of Lunit's presence in North America, with its AI solutions now deployed at over 200 imaging centers and hospitals across the country.

The integration of Lunit's AI technology with Volpara's breast health expertise has enabled the company to deliver AI-powered breast cancer screening to a growing number of healthcare providers, including Rezolut, SimonMed Imaging, and UC Davis Health. By June 2025, approximately 350 to 400 radiologists are expected to utilize Lunit's technology.

Lunit and Volpara have also introduced a comprehensive Ecosystem for Cancer Detection and Care, which aims to unify AI technologies for lesion detection, workflow optimization, quality control, and patient engagement. This initiative is designed to provide clinicians with actionable insights and scalable solutions across the cancer care continuum.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more